/Investor DB

Trans-Pacific Technology Fund

Venture capital

Taipei · Seed–Growth · 17 people tracked

Find your way into Trans-Pacific Technology Fund

Sign up to see every warm intro you have to Trans-Pacific Technology Fund

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Trans-Pacific Technology Fund team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

TPTF is a multi-stage, technology-driven venture capital fund focused on disruptive platform technologies. It invests across advanced materials, health and life sciences, information and communications technology (ICT), IoT, and robotics/automation. Positioning itself as an innovation-driven, added-value partner, TPTF works actively with portfolio company leadership to support growth through capital, expertise, and global connections. Underpinned by a people-first philosophy that values entrepreneurs, the firm leverages an extensive network of collaborative partners to maintain a global investment scope spanning Asia, North America, and Europe.

Source: firm website, verified Oct 1, 2026.

Stage
Seed–Growth
HQ
Taipei, TW
Instruments
Equity
Founded
2014
Tracked investments
13
Unicorns
1
IPOs
2

Team · 17 people

from the firm's website & public directories
Glenn· Managing Partner
Herb· Managing Partner
Glenn Kline· Managing Partnerin
Herb Lin· Managing Partner
Alex Yang· Venture Partner
Boh Soon Lim· Venture Partner
Mike Tung· Venture Partner
Nitin Gupta· Venture Partner
Volker Heistermann· Venture Partner
Fiya Lee· Investment Professional
Spencer Karrington· Associate
Barry Lee· Investment Professional
Ben Chou· Investment Professional
Bruce Han· Investment Professional
Jim Li· Investment Professional
Lizzie Lee· Investment Professional
Sarah Chiu· Investment Professional

What they invest in

from 10 of 13 portfolio companies

Healthtech ×7Biotech ×6Medical Devices ×3AI & Machine Learning ×2Digital Health ×2Enterprise Software ×2AgTech ×1Cloud Computing ×1

HQs:United States×7Indonesia×2Taiwan×1

Investments · 13 tracked

founders shown can be your intro path

By year:2018 · 22017 · 12014 · 14 dated

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNA

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

Pyxis Oncologypyxisoncology.comin𝕏NASDAQ: PYXS

Pyxis Oncology develops antibody-drug conjugates and immunotherapies targeting difficult-to-treat cancers to improve patient outcomes.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

Thomas Civik(Interim Chief Executive Officer, Director)

BoardDavid Steinberg(Executive Officer, Director)inChristoph Westphal(Director)Geeta Vemuri(Director)inJak Knowles(Director)John Flavin(Director)

Co-investorsAgent CapitalLifeSci Venture PartnersLongwood FundPfizer Venture InvestmentsRA CapitalRTW Investments L.P.

Bened Biomedicalbenedbiomed.com

Bened Biomedical develops probiotic products focused on neurological health, serving customers across more than 40 markets worldwide through regionally located manufacturing partners.

BiotechHealthtechWellness & FitnessTaipei, TW

Crown BioSciencecrownbio.comin𝕏

Crown Bioscience is a contract research organization based in California providing discovery, preclinical, and translational platforms and services for oncology and immuno-oncology drug development.

BiotechHealthtechMedical DevicesCalifornia, US

Co-investorsAcorn Pacific VenturesGRC SinogreenLAVLilly Asia VenturesQiming Venture Partners

Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOCV PartnersOMX Ventures+2 more

Katakata.aiin𝕏Aug 2017

Kata.ai provides a large language model that lets brands and enterprises build intelligent chatbots for marketing, commerce, and behavioral data collection across social and chat apps such as LINE, Facebook, and WhatsApp.

AI & Machine LearningE-commerceEnterprise SoftwareHR TechMarketing TechSaaSSales Tech

Ahmad Rizqi Meydiarso(Founder)inChristian FrankeIrzan Raditya(Founder)inReynir Fauzan(Founder)inWahyu Wrehasnaya(Founder)in

Co-investors500 GlobalAC VenturesRed Sails InvestmentSpiral VenturesConvergence VenturesMDI Ventures

Rancher Labsrancher.comin𝕏

Rancher is an open-source container management platform that provides enterprise-grade Kubernetes orchestration and management across data centers, clouds, and edge environments.

Cloud ComputingDeveloper ToolsEnterprise Software

Sheng Liang(Founder)inDarren Shepherd(Founder)Shannon Williams(Founder)Will Chan(Founder)

Co-investorsGRC SinogreenMayfield FundTitanium VenturesNexus Venture Partners

Reyrey.idin𝕏

Rey.id addresses inefficiencies in the healthcare industry through solutions targeting health service provision, fraud prevention, and chronic disease management.

Digital HealthHealthtechInsurTech

Co-investorsGenesia Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Applied BioCodeGet HealGoogol TechnologyHealMegaPro Therapeutics

Exits · 2

2 IPOs

Ginkgo BioworksNYSE: DNAPyxis OncologyNASDAQ: PYXS

Frequently asked questions

How many investments has Trans-Pacific Technology Fund made?
Trans-Pacific Technology Fund has 13 tracked investments, 2 of which have exited.
What stage does Trans-Pacific Technology Fund invest at?
Trans-Pacific Technology Fund invests at the Seed, Series A, Series B, Growth stages.
What sectors does Trans-Pacific Technology Fund focus on?
Trans-Pacific Technology Fund focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Consumer, Data & Infrastructure, Deep Tech, Enterprise Software, Hardware, Healthtech, InsurTech, IoT, Medical Devices, New Materials, Robotics, SaaS.
Where is Trans-Pacific Technology Fund located?
Trans-Pacific Technology Fund is headquartered in Taipei, TW.
Who does Trans-Pacific Technology Fund co-invest with?
Trans-Pacific Technology Fund most often shares deals with GRC Sinogreen, B3 Holding, OMX Ventures, among 50 tracked co-investors.

Similar investors

Featured in lists